Dr Liza McCann

Dr Liza McCann is an eminent Consultant Paediatrician and Consultant Paediatric Rheumatologist dedicated to providing comprehensive care for infants, children, and young people. Specialising in complex childhood autoimmune and inflammatory conditions, Dr McCann works within multidisciplinary teams to ensure every young patient receives personalised, compassionate, and high-quality medical management. Her clinical approach emphasises holistic support for children and their families, tailoring treatment plans to enhance long-term health outcomes and overall quality of life.

Dr McCann undertook her medical education at the University of London, earning a Bachelor of Science in Pathology and Basic Medical Sciences in 1992, followed by her Bachelor of Medicine, Bachelor of Surgery with Distinction in 1995. She achieved Membership of the Royal College of Paediatrics and Child Health in 1998 and later completed a Master of Medical Science with Merit at the University of Leeds in 2004. As a Fellow of the Royal College of Paediatrics and Child Health, Dr McCann maintains active involvement in leading professional organisations, including international networks dedicated to advancing paediatric rheumatology research and clinical standards.

Her clinical focus encompasses a broad spectrum of paediatric rheumatological diseases, with expertise in juvenile dermatomyositis, juvenile idiopathic arthritis, paediatric systemic lupus erythematosus, autoinflammatory syndromes, and vasculitis. Dr McCann utilises advanced diagnostic tools such as nailfold capillaroscopy to evaluate microvascular health and guides targeted treatment plans incorporating biological therapies, disease-modifying anti-rheumatic medications, and tailored immunosuppressive regimes. Her work in ambulatory care and complex multisystem disease clinics ensures continuity of care for patients navigating long-term physical health challenges.

In addition to her clinical practice, Dr McCann is an active researcher and Associate Professor who contributes to national and international consensus guidelines for childhood rheumatic disorders. She plays a pivotal role in clinical trials and registry studies designed to standardise treatments, improve diagnostic accuracy, and evaluate therapeutic safety. Through her dedication to medical research, clinical governance, and direct patient care, Dr McCann remains committed to advancing the standard of healthcare for young patients and their families.